| 
Results for celgene. Search took 0.14 seconds.
REVLIMID® (lenalidomide)-Dexamethasone Combo, Effective in Multiple Myeloma
in Straightfromthedoc, on November 23, 2007
...Multiple myeloma is a cancer that occurs in the blood-making cells of bone marrow.
A product of Celgene , REVLIMID® (lenalidomide) is an oral medication which treats without the ravages of chemot...
Big Biotech Stocks To Perform Better in 2007
in The Biotech Weblog, on January 12, 2007
...a good year for biotech firms, but analysts say big biotech companies like Amgen , Genentech , Celgene and Gilead Sciences would perform better in 2007.
"We're looking forward to an ...
Morgan Stanley Expect Favorable Returns from Large Biotech Companies
in The Biotech Weblog, on July 20, 2006
...infections. Latest approved drug candidate: Atripla ,a three-in-one tablet against HIV.
and Celgene : Focuses on cancer and inflammatory disease therapeutics. Top products include Thalomid and R...
Top 20 Molecular Millionaires
in The Biotech Weblog, on May 31, 2006
...$50-100 Million
3. William A. Haseltine, Ph.D., Human Genome Sciences
4. Sol J. Barer, Ph.D., Celgene
5. Wayne T. Hockmeyer, Ph.D., MedImmune
$20-50 Million
6. Leonard Schleifer, ...
FDA Approves Thalomid For Multipple Myeloma Therapy
in The Biotech Weblog, on May 30, 2006
...
Thalomid (generic: thalidomide) is a drug manufactured by Celgene, Inc , for the treatment of certain symptoms associated with Erythema Nodosum Leprosum (ENL) . It is an inhibitor of tumor ne...